11 December 2020

Rheon Labs completes £4m equity fundraise

Rheon Labs Ltd has raised £4m in equity funding in a transaction that follows on from its £7m Series A round in 2019. LGB acted as arranger of both transactions.

Rheon Labs is operating in the highly commercial field of active materials. The company’s technologies are based on highly strain-sensitive polymers that temporarily stiffen when bent, stretched or pressed. Rheon’s current focus is on the branded consumer goods sector. Current applications include sports helmets, body armour, footwear, touchpoints such as grips and performance apparel. The funding will help the company address its pipeline of commercial opportunities and develop its R&D programme in conjunction with new applications.

The fundraising received strong support from existing shareholders who participated in the transaction in 2019 and also attracted a number of new investors. The transaction was completed in a little over one month. Investors were encouraged by how much the company’s commercial engagements and operations had broadened in the last two years and were excited by the prospect of seeing Rheon’s materials in a wide range of consumer products.

Recent Articles

17 February 2021

Scancell's Share Price Soars on Hopes for a "Universal Vaccine"

The share price of Scancell Holdings plc, (AIM:SCLP) rose sharply from 14p to a high of 28p on Monday 15th February before settling to close at 20p. The Read more

News & Insights

4 February 2021

MaxCyte announces £40 million subscription

MaxCyte, Inc. Read more

Deals

28 January 2021

After the flood - prospects for 2021 and beyond

Last week, Ivan Sedgwick debated prospects for 2021 in a webcast for LGB & Co. Ltd clients with Helen Thomas, CEO of Blonde Money. Read more

News & Insights